Journal article

Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study

Joaquin Mateo, Heather H Cheng, Himisha Beltran, David Dolling, Wen Xu, Colin C Pritchard, Helen Mossop, Pasquale Rescigno, Raquel Perez-Lopez, Verena Sailer, Michael Kolinsky, Ada Balasopoulou, Claudia Bertan, David M Nanus, Scott T Tagawa, Heather Thorne, Bruce Montgomery, Suzanne Carreira, Shahneen Sandhu, Mark A Rubin Show all

European Urology | ELSEVIER SCIENCE BV | Published : 2018

Grants

Awarded by NIH/NCI


Funding Acknowledgements

This work was supported by a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research (SU2C-AACR-DT0712). We also acknowledge support from Movember and Prostate Cancer UK, and from the KConFab consortium (Kathleen Cuningham Foundation Consortium for research into familial breast cancer; Australia) for providing data for this report. J. Mateo, H. Cheng, H. Beltran, and C. Pritchard were supported by Prostate Cancer Foundation Young Investigator Awards. We also acknowledge funding support from NIH/NCI (P50CA097186), the Institute for Prostate Cancer Research (Seattle, WA, USA), a Medical Research Council-Prostate Cancer UK fellowship (J. Mateo), an Experimental Cancer Medical Centre grant, and a Biomedical Research Centre grant to the ICR/Royal Marsden. S. Sandhu was supported by a Prostate Cancer Foundation of Australia Young Investigator Award.